Michael Raab sold $177k of ARDX
President & CEO at ARDELYX, INC.. 41,666 shares at an average of $4.25, traded May 2, 2025, filed May 5, 2025.
Score components
- +25RoleCEO
- +12Trade size$177k at market
- 0Share of holdings soldSold 2.5% of holdings
- 0ClusterNo other insider selling within 14 days
- -15Exercise and sellShares came from an option exercise in the same filing
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m -1.2%, 3m +17.5%, 6m +58.5%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001628280-25-022355, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| May 2, 2025 | MOption exercise Common Stock10b5-1 | +20,833 | $0.99 | $21k | 1,636,420 | May 5, 2025 |
| May 2, 2025 | SOpen-market sale Common Stock10b5-1 | -41,666 | $4.25 | $177k | 1,594,754 | May 5, 2025 |
| May 2, 2025 | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -20,833 | $0.00 | $0 | 415,834 | May 5, 2025 |
Related signals
Other insiders at ARDELYX, INC. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 38Weak | ARDELYX, INC. | John E Bishop See Remarks | $76k 19,750 shares | -6% | |
| 53Moderate | ARDELYX, INC. | Michael Raab President & CEO | $226k 58,574 shares | -3% | |
| 36Weak | ARDELYX, INC. | Laura A Williams Chief Patient Officer | $41k 10,739 shares | -3% | |
| 35Weak | ARDELYX, INC. | Mike Kelliher Chief Business Officer | $30k 7,758 shares | -2% | |
| 36Weak | ARDELYX, INC. | Eric Duane Foster Chief Commercial Officer | $33k 8,562 shares | -2% | |
| 30Weak | ARDELYX, INC. | Joseph James Reilly See Remarks | $15k 3,982 shares | -3% | |
| 37Weak | ARDELYX, INC. | James Parker Brady Chief Human Resources Officer | $58k 15,136 shares | -6% | |
| 37Weak | ARDELYX, INC. | Susan Hohenleitner Chief Financial Officer | $6,009 1,558 shares | -1% | |
| 2Weak | ARDELYX, INC. | Michael Raab President & CEO | $211k 41,668 shares | -2% | |
| 11Weak | ARDELYX, INC. | Laura A Williams Chief Patient Officer | $490k 81,898 shares | -18% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.